Corcept Therapeutics (CORT) Operating Leases (2019 - 2026)
Corcept Therapeutics (CORT) reported Operating Leases of $8.0 million for Q1 2026, up 17.19% on a YoY basis from $6.8 million in Q1 2025, and up 59.47% sequentially from $5.0 million in Q4 2025.
Corcept Therapeutics (CORT) Operating Leases (2019 - 2026) Analysis & Trends
Corcept Therapeutics (CORT) has 7 years of Operating Leases data on file, last reported at $8.0 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Leases rose 17.19% year-over-year to $8.0 million; the trailing twelve-month figure through Mar 2026 stood at $8.0 million (up 17.19% YoY), and the FY2025 full-year result was $5.0 million, down 17.75% from the prior year.
- Operating Leases rose to $8.0 million in Q1 2026, from $5.0 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $8.0 million in Q1 2026 to a low of $76000.0 in Q1 2024.
- A 5-year average of $3.6 million and a median of $3.9 million in 2022 frame the typical range for Operating Leases.
- Across the five-year window, Operating Leases sank 86.88% in 2023 and jumped 8893.42% in 2025, its largest moves.
- Tracing CORT's Operating Leases over 5 years: stood at $1.1 million in 2022, then plunged by 80.31% to $225000.0 in 2023, then jumped by 2614.22% to $6.1 million in 2024, then dropped by 17.75% to $5.0 million in 2025, then surged by 59.47% to $8.0 million in 2026.
- Business Quant data shows CORT's Operating Leases at $8.0 million in Q1 2026, $5.0 million in Q4 2025, and $5.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Corcept Therapeutics | 9.99 Bn | 9.65 Bn | 162.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.01 Mn |
| Dec 31, 2025 | 5.02 Mn |
| Sep 30, 2025 | 5.31 Mn |
| Jun 30, 2025 | 5.59 Mn |
| Mar 31, 2025 | 6.84 Mn |
| Dec 31, 2024 | 6.11 Mn |
| Sep 30, 2024 | 6.79 Mn |
| Jun 30, 2024 | 5.63 Mn |
| Mar 31, 2024 | 76,000.00 |
| Sep 30, 2023 | 225,000.00 |
| Jun 30, 2023 | 297,000.00 |
| Mar 31, 2023 | 575,000.00 |
| Dec 31, 2022 | 1.14 Mn |
| Sep 30, 2022 | 1.71 Mn |
| Jun 30, 2022 | 2.26 Mn |
| Mar 31, 2022 | 2.80 Mn |
| Dec 31, 2020 | 501,000.00 |
| Sep 30, 2020 | 997,000.00 |
| Jun 30, 2020 | 800,000.00 |
| Mar 31, 2020 | 1.54 Mn |